MitoRx Therapeutics
About:
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
Website: https://www.mitorxtherapeutics.com/
Top Investors: Future Planet Capital, UK Innovation & Science Seed Fund, Empirical Ventures, The Fink Family Office, Longevitytech.fund
Description:
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
Total Funding Amount:
4M GBP
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Harwell, Oxfordshire, United Kingdom
Founded Date:
2016-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-12-13
IPO Status:
Private
Industries:
© 2025 bioDAO.ai